Abbvie withdraws suit as data transparency legislation gets EU vote
Abbvie Inc. has withdrawn the legal case it took out to prevent the EMA from publishing the clinical study reports relating to its anti-TNF alpha drug, Humira, after the agency accepted a new set of redacted documents and agreed with the company’s rationale for removing certain commercially confidential information from the reports at the center of the litigation.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter